Frontiers in Oncology | Genitourinary Oncology

Systematic Review

Published on 19 Jun 2024

Prognostic value of systemic immune-inflammation index in patients with metastatic renal cell carcinoma treated with systemic therapy: a meta-analysis

in Genitourinary Oncology

Juan Xu
Pingrun Chen
Shangqi Cao
Xu Hu
Xiang Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1404753

1,516 views
3 citations

Systematic Review

Published on 14 Jun 2024

Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients

in Genitourinary Oncology

Ziyi Yu
Zhencheng Xiong
Jinchao Ma
Peng Du
Shuo Wang
Jia Liu
Yudong Cao
Yong Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1342996

1,506 views
2 citations

Perspective

Published on 14 Jun 2024

Cardio-oncology in advanced prostate cancer

in Genitourinary Oncology

Kenneth Chen
Ting Hong Wong
Yu Guang Tan
Kae Jack Tay
Wei Chong Tan
Johan Chan
Henry Ho
Christopher Cheng
Jeremy Yuen-Chun Teoh
Peter Ka-Fung Chiu

Frontiers in Oncology

doi 10.3389/fonc.2024.1386597

3,444 views
4 citations

Correction

Published on 13 Jun 2024

Corrigendum: Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer

in Genitourinary Oncology

Won Sik Ham
Jee Soo Park
Won Sik Jang
Jongchan Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1427226

789 views

Original Research

Published on 12 Jun 2024

Enfortumab vedotin–related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience

in Genitourinary Oncology

Evangelia Vlachou
Burles Avner Johnson
David McConkey
Yuezhou Jing
Andres Matoso
Noah M. Hahn
Jean Hoffman-Censits

Frontiers in Oncology

doi 10.3389/fonc.2024.1377842

3,990 views
10 citations

Original Research

Published on 11 Jun 2024

A semi-automatic deep learning model based on biparametric MRI scanning strategy to predict bone metastases in newly diagnosed prostate cancer patients

in Genitourinary Oncology

Song Xinyang
Shen Tianci
Hu Xiangyu
Zhang Shuang
Wang Yangyang
Du Mengying
Xu Tonghui
Zhou Jingran
Yang Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1298516

1,922 views
4 citations

Original Research

Published on 04 Jun 2024

Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study

in Genitourinary Oncology

Hong Du
Wenjuan Xie
Wenqiang Chen
Yu Wang
Yong Liao
Mingxing Qiu
Jun Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1348324

1,283 views

Original Research

Published on 04 Jun 2024

Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study

in Genitourinary Oncology

Rosalyne L. Westley
Sophie E. Alexander
Edmund Goodwin
Alex Dunlop
Simeon Nill
Uwe Oelfke
Helen A. McNair
Alison C. Tree

Frontiers in Oncology

doi 10.3389/fonc.2024.1379596

1,817 views
5 citations

Original Research

Published on 03 Jun 2024

Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program

in Genitourinary Oncology

Se Hoon Park
Sang Joon Shin
Sun Young Rha
Seung-Hoon Beom
Ho Kyung Seo
Bhumsuk Keam
Miso Kim
Yoon-Hee Hong
Shinkyo Yoon
Jae-Lyun Lee

Frontiers in Oncology

doi 10.3389/fonc.2024.1403120

2,679 views
3 citations

Systematic Review

Published on 03 Jun 2024

A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma

in Genitourinary Oncology

Xiaopeng Lan
Mei Feng
Ji Lv
Luchen Zhang
Pengcheng Hu
Yizhen Wang
Yanhui Zhang
Shen Wang
Chunzhao Liu
Chunlei Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364997

1,455 views
1 citation

Review

Published on 31 May 2024

The role of metabolic reprogramming in kidney cancer

in Genitourinary Oncology

Ziyi Chen
Xiaohong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1402351

2,562 views
1 citation

Case Report

Published on 31 May 2024

Ureter mixed neuroendocrine-non-neuroendocrine neoplasm: a case report and literature review

in Genitourinary Oncology

Bing Zhou
Xing Gan
Xiaohua Li
Lizi Peng
Hua Hao

Frontiers in Oncology

doi 10.3389/fonc.2024.1390350

1,386 views

Original Research

Published on 28 May 2024

Laparoscopic nephron-sparing surgery for complex renal cystic lesions: a single-center experience

in Genitourinary Oncology

Dexin Dong
Yushi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1398347

1,355 views

Case Report

Published on 28 May 2024

Avelumab maintenance therapy for node-positive muscle invasive bladder cancer: a report of two cases

in Genitourinary Oncology

Darren M. C. Poon
Lap Yin Ho
Yiu Ming Kwong

Frontiers in Oncology

doi 10.3389/fonc.2024.1397738

1,857 views
1 citation

Original Research

Published on 28 May 2024

Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer

in Genitourinary Oncology

Daniel Uysal
Blerta Thaqi
Alexander Fierek
David Jurgowski
Zoran V. Popovic
Fabian Siegel
Maurice Stephan Michel
Philipp Nuhn
Thomas Stefan Worst
Philipp Erben

Frontiers in Oncology

doi 10.3389/fonc.2024.1370303

2,233 views
2 citations

Editorial

Published on 24 May 2024

Editorial: PET/CT and MRI in prostate cancer

in Genitourinary Oncology

Fabio Grizzi
Gianluigi Taverna

Frontiers in Oncology

doi 10.3389/fonc.2024.1421542

1,630 views
1 citation